NIH PAR · NCI · R21
PAR-25-143: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance…
- NOFO number
- PAR-25-143
- Type
- PAR
- Activity code
- R21
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Optional
- Posted
- Oct 31, 2024
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2028
PAR-25-143 due dates
4 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-143
NIH RePORTER lists 10 projects funded under PAR-25-143 in FY2022–FY2026, with $3.4M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
10
Distinct projects, FY2022–FY2026
New awards
10
Type 1 (new project) award records
NIH funding
$3.4M
Award dollars under PAR-25-143, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 11 | 10 | $3.4M |
Institutions with the most funding
- Massachusetts General Hospital$474K · 1 project
- University of California Los Angeles$447K · 1 project
- Duke University$444K · 1 project
- University of Texas at Austin$442K · 1 project
- University of Texas Hlth Sci Ctr Houston$401K · 1 project
- Purdue University$347K · 1 project
- Albert Einstein College of Medicine$252K · 1 project
- University of North Texas Hlth Sci Ctr$195K · 1 project
Funding institutes
- NCI$848K · 2
- NIA$821K · 2
- NIAID$447K · 3
- NCCIH$444K · 1
- NIMH$442K · 1
- FIC$189K · 1
- NINDS$183K · 1
Activity codes funded
- R2111 records
Most recent new awards
- Kuishi-TBI App: A mobile health application for traumatic brain injury care in Moshi, Tanzania (opens NIH RePORTER)
Kilimanjaro Christian Medical Centre · 1R21NS151171-01 · NINDS · Notice Sep 7, 2026
$183KR21
- Unraveling the Role of Water Hyacinth in Modulating Schistosomiasis to Facilitate Scaling a Proven Disease Control Intervention (opens NIH RePORTER)
University of Notre Dame · 1R21TW013266-01 · FIC · Notice Aug 31, 2026
$189KR21
- Optimizing the geographic expansion of cervical cancer screening & treatment in remote and rural settings (opens NIH RePORTER)
University of California Los Angeles · 1R21CA313908-01 · NCI · Notice Aug 28, 2026
$447KR21
- Diffusion Beyond Hospital Walls: Effect of GEDA Implementation on Prehospital Care of Older Adults (opens NIH RePORTER)
Massachusetts General Hospital · 1R21AG103608-01 · NIA · Notice Aug 24, 2026
$474KR21
- Enhanced Navigation to Improve Pain-related Psychological Support and Resource Use in Orthopedics (opens NIH RePORTER)
Duke University · 1R21AT013400-01A1 · NCCIH · Notice Aug 17, 2026
$444KR21
- Integrating Family Navigation in Part-C Early Intervention Systems (opens NIH RePORTER)
University of Texas at Austin · 1R21MH142906-01 · NIMH · Notice Aug 14, 2026
$442KR21
What its predecessor PAR-22-109 funded
PAR-25-143 reissues PAR-22-109. Its funding history is the best guide to who wins under this program: 16 projects and $6.0M in FY2022–FY2026.
Projects funded
16
Distinct projects, FY2022–FY2026
New awards
16
Type 1 (new project) award records
NIH funding
$6.0M
Award dollars under PAR-22-109, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 5 | 5 | $1.2M |
| FY2024 | 10 | 6 | $1.9M |
| FY2025 | 15 | 5 | $2.5M |
| FY2026 | 5 | 0 | $505K |
Institutions with the most funding
- University of Pennsylvania$894K · 2 projects
- University of Kentucky$461K · 1 project
- New York University$443K · 1 project
- Northwestern University$440K · 1 project
- Univ of Massachusetts Med Sch Worcester$425K · 1 project
- University of Pittsburgh at Pittsburgh$389K · 1 project
- University of South Carolina at Columbia$387K · 1 project
- Yale University$381K · 1 project
Funding institutes
- NICHD$1.3M · 7
- NCI$1.1M · 7
- FIC$1.0M · 6
- NIAID$842K · 4
- NIDA$630K · 3
- NIMH$440K · 2
- NIA$389K · 2
- NINR$373K · 4
Activity codes funded
- R2135 records
Most recent new awards
- A Delphi Study of Implementation Strategies for Cervical Cancer Control Policies in Africa (opens NIH RePORTER)
New York University · 1R21CA293319-01A1 · NCI · Notice Sep 22, 2025
$443KR21
- Evaluating the adoption, implementation, and maintenance of a cervical precancer treatment in El Salvador (opens NIH RePORTER)
Cleveland Clinic Lerner Com-Cwru · 1R21CA293274-01A1 · NCI · Notice Sep 10, 2025
$184KR21
- Development of a disparities in labor outcomes dashboard: an implementation strategy for obstetric interventions. (opens NIH RePORTER)
University of Pennsylvania · 1R21HD114902-01A1 · NICHD · Notice Aug 28, 2025
$447KR21
- Mechanisms of Action for mobile SMS PrEP adherence intervention (opens NIH RePORTER)
University of Washington · 1R21NR021354-01A1 · NINR · Notice Jul 28, 2025
$144KR21
- PROTECT-Wazee: Improving care for older adult trauma patients in Tanzania: guideline adaptation for low -resource setting (opens NIH RePORTER)
Kilimanjaro Christian Medical Centre · 1R21TW013139-01A1 · FIC · Notice Jun 5, 2025
$182KR21
- Built environment approaches to physical activity: Testing community-driven implementation strategies (opens NIH RePORTER)
Chn Nebraska · 1R21CA280503-01A1 · NCI · Notice Sep 10, 2024
$141KR21
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
20 NIH institutes and offices take applications under PAR-25-143. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- NHGRI · National Human Genome Research Institute
- NIA · National Institute on Aging
- NIAAA · National Institute on Alcohol Abuse and Alcoholism
- NIAID · National Institute of Allergy and Infectious Diseases
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCD · National Institute on Deafness and Other Communication Disorders
- NIDCR · National Institute of Dental and Craniofacial Research
- NIDA · National Institute on Drug Abuse
- NIEHS · National Institute of Environmental Health Sciences
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- NINR · National Institute of Nursing Research
- NIMHD · National Institute on Minority Health and Health Disparities
- FIC · Fogarty International Center
- NCCIH · National Center for Complementary and Integrative Health
- THRO
- ODP
- OBSSR
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Mar 31, 2025
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
Jan 17, 2025 · NOT-NS-25-016
Notice of Change: NINDS Interests for PAR-25-143 Dissemination and Implementation Research in Health R21 Clinical Trial Optional)".
Dec 20, 2024 · NOT-CA-25-001
Notice of Correction to the Dissemination and Implementation Research in Health" Notices of Funding Opportunity PAR-25-143 and PAR-25-144. See Notice NOT-CA-25-001.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 18 NOSIs to PAR-25-143; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- The combined budget for direct costs for the two-year project period may not exceed 275,000. No more than 200,000 may be requested in a single year.
- Project period
- The maximum project period is 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-109.
- Companion NOFOs: PAR-25-144, PAR-25-233.
Other open NOFOs for R21
- PAR-25-346Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
- PAR-25-321Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)NCI · next due Oct 16, 2026
- PAR-25-070Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
- PAR-25-244Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
- PA-25-253Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)NCI · next due Oct 16, 2026
- PAR-25-044Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.